Danazol has potential to cause PKC translocation, cell cycle dysregulation, and apoptosis in breast cancer cells

Suman Jyoti Deka, Ashalata Roy, Vibin Ramakrishnan, Debasis Manna, Vishal Trivedi
In: Chemical Biology & Drug Design · 2016 · vol. 89(6) , pp. 953–963 · doi:10.1111/cbdd.12921 · PMID:27933735 · W2559837447
article OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed View at publisher

Abstract

of 31 ± 2.63 and 65 ± 4.27 μg/ml, respectively. DNA fragmentation and flow cytometry experiments revealed that the cell death follows the apoptotic pathway. It affects mitochondrial membrane potentials and releases cytochrome-C from mitochondria to induce downstream apoptosis in breast cancer cells. Hence, the current study may help clinicians to re-design their treatment strategy to optimize therapeutic potentials of the molecule.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

Cited by (1)

References (44)

Cited by (1)

SciLite annotations

chemicals 4
danazol danazol danazol danazol

Source provenance

openalex
last seen: 2026-05-11T03:41:56.425819+00:00
scilite
last seen: 2026-05-18T04:57:49.680383+00:00
unpaywall
last seen: 2026-06-14T06:15:46.576397+00:00
License: CC0 · commercial use OK